Childhood CancerNCT07606443
COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care
A study testing Family-Centered Communication Intervention in people with Childhood Cancer, run by Stanford University at 1 site in United States.
Trial summary
This study will test a novel intervention to facilitate family-centered communication among Hispanic/Latino (H/L) young adult childhood cancer survivors (YA-CCS), their support persons, and their clinicians through collaboration between the clinic and a community-based organization. Read more about this study
- Who is it for?
- Ages 18 to 25 yearsHealthy volunteers can take part
- Conditions the study is for
- Childhood Cancer
- What is being tested?
- Family-Centered Communication Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 18 participants
- Where
- 1 siteUnited States
- Study dates
- 10 Sep 2026to Jul 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Childhood cancer survivor previously treated with chemotherapy and/or radiation therapy
- Currently age 18-25 years
- Identifies as Hispanic/Latino
- Currently ≥5 years post cancer diagnosis
- Fluent in English or Spanish
- Receives medical care at Stanford
- Lives within Jacob's Heart service area (zip codes within Monterey, Santa Cruz, Santa Clara, San Benito Counties: https://www.jacobsheart.org/service-area)
- Ability to understand and the willingness to provide written informed consent.
Who cannot join
- 1. Lack of proficiency in written and spoken English or Spanish
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Stanford University
Palo Alto, California, 94304
Stephanie Smith, MD, MPH, 209-609-0208, smithsm@stanford.edu
Stephanie Smith, MD, MPH
About this study
This study will test a novel intervention to facilitate family-centered communication among Hispanic/Latino (H/L) young adult childhood cancer survivors (YA-CCS), their support persons, and their clinicians through collaboration between the clinic and a community-based organization.
- Conditions
- Childhood Cancer
- Being tested
- Family-Centered Communication Intervention
- Keywords
- cancer, hispanic, young adult
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Family-Centered Communication InterventionBehavioural
A novel family-centered communication intervention designed to facilitate communication among Young Adult Cancer Survivors (YA-CCS), their chosen support person, and clinicians through collaboration between the clinic and a community-based organization. The intervention includes pre-visit and post-visit sessions delivered by a community health worker and timed around a standard-of-care survivorship clinic visit.
| Study group | Role | What they receive |
|---|---|---|
| Family-Centered Communication | Experimental | Young Adult Cancer Survivors (YA-CCS)-support person dyads receive a family-centered communication intervention delivered by a community health worker and coordinated around a standard-of-care survivorship clinic visit. Receives: Behavioral: Family-Centered Communication Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of invited young adult cancer survivor-support person dyads enrolled
Feasibility assessed by the proportion of invited dyads who enroll in the study.
Measured: From recruitment initiation through completion of study enrollment, up to 24 months
Proportion of enrolled young adult cancer survivors completing all intervention components
Feasibility assessed by the proportion of enrolled young adult cancer survivor participants who complete all intervention components.
Measured: From intervention initiation through intervention completion, up to 3 weeks
Mean Theoretical Framework of Acceptability questionnaire score
Acceptability assessed using participant-reported Theoretical Framework of Acceptability (TFA) questionnaire scores. Scores range from 1-5, with higher scores indicating greater acceptability.
Measured: Post-intervention, within 2 months after intervention completion
Mean Satisfaction With Visit Preparation questionnaire score
Acceptability assessed using participant-reported Satisfaction With Visit Preparation questionnaire scores. Scores range from -10 to 10, with higher scores indicating greater satisfaction.
Measured: Post-intervention, within 2 months after intervention completion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 May 2026
- Study start10 Sep 2026
- Primary completionJul 2028 (estimated)
- Study completionJul 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Childhood CancerStudies of the same condition, open and under way.
- More trials run by Stanford UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 18 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Stanford University
- Sponsor type
- University, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Responsible party
- Sponsor
- Investigators
- Stephanie Smith, MD, MPH, Principal investigator, Stanford University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07606443
- Sponsor's protocol ID
- IRB-85827
- Other IDs
- 5K08CA285829, NCI-2026-06570
- Status last verified
- Nov 2026
- First submitted
- 11 May 2026
- Last updated
- 4 Nov 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care
- ClinicalTrials.gov ID
- NCT07606443
- Acronym / sponsor ID
- IRB-85827
- Conditions
- Childhood Cancer
- Keywords
- cancer, hispanic, young adult
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 18 participants (estimated)
- Lead sponsor
- Stanford UniversityUniversity, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Study start
- 10 Sep 2026 (actual)
- Primary completion
- Jul 2028 (estimated)
- Study completion
- Jul 2028 (estimated)
- First posted
- 26 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will test a novel intervention to facilitate family-centered communication among Hispanic/Latino (H/L) young adult childhood cancer survivors (YA-CCS), their support persons, and their clinicians through collaboration between the clinic and a community-based organization.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Family-Centered Communication | Experimental | Behavioral: Family-Centered Communication InterventionYoung Adult Cancer Survivors (YA-CCS)-support person dyads receive a family-centered communication intervention delivered by a community health worker and coordinated around a standard-of-care survivorship clinic visit. |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- Childhood cancer survivor previously treated with chemotherapy and/or radiation therapy
- Currently age 18-25 years
- Identifies as Hispanic/Latino
- Currently ≥5 years post cancer diagnosis
- Fluent in English or Spanish
Key exclusion criteria (1 listed)
- 1. Lack of proficiency in written and spoken English or Spanish
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Family-Centered Communication InterventionA novel family-centered communication intervention designed to facilitate communication among Young Adult Cancer Survivors (YA-CCS), their chosen support person, and clinicians through collaboration between the clinic and a community-based organization. The intervention includes pre-visit and post-visit sessions delivered by a community health worker and timed around a standard-of-care survivorship clinic visit. | Behavioural | Family-Centered Communication |
Primary outcome
Proportion of invited young adult cancer survivor-support person dyads enrolled
Time frame: From recruitment initiation through completion of study enrollment, up to 24 months
Feasibility assessed by the proportion of invited dyads who enroll in the study.
Proportion of enrolled young adult cancer survivors completing all intervention components
Time frame: From intervention initiation through intervention completion, up to 3 weeks
Feasibility assessed by the proportion of enrolled young adult cancer survivor participants who complete all intervention components.
Mean Theoretical Framework of Acceptability questionnaire score
Time frame: Post-intervention, within 2 months after intervention completion
Acceptability assessed using participant-reported Theoretical Framework of Acceptability (TFA) questionnaire scores. Scores range from 1-5, with higher scores indicating greater acceptability.
Mean Satisfaction With Visit Preparation questionnaire score
Time frame: Post-intervention, within 2 months after intervention completion
Acceptability assessed using participant-reported Satisfaction With Visit Preparation questionnaire scores. Scores range from -10 to 10, with higher scores indicating greater satisfaction.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Nov 2026.
Related trials for Childhood Cancer
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
RecruitingObservational study
Psychological Benefits of a Normalized Camping Experience for Children With Cancer
Pediatric Cancer
Recruiting
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
Solid Tumor, Adult, Solid Tumor, Childhood
RecruitingObservational study
The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network
Knowledge, Attitudes, Practice
Recruiting
Facial Expression Awareness Training to Understand and Recognize Emotions
Survivors of Pediatric Brain Tumors, Pediatric Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Stephanie Smith, MD, MPH principal investigator
Stanford University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Family-Centered Communication Intervention in people with Childhood Cancer, run by Stanford University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 4 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Stephanie Smith, MD, MPH (209-609-0208, smithsm@stanford.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of invited young adult cancer survivor-support person dyads enrolled (time frame: From recruitment initiation through completion of study enrollment, up to 24 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2026.